RPTX
Repare Therapeutics (RPTX)
$03
About Repare Therapeutics (RPTX)
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
Details
Daily high
$1.09
Daily low
$1.03
Price at open
$1.07
52 Week High
$4.90
52 Week Low
$1.03
Market cap
45.9M
Dividend yield
0.00%
Volume
267,997
Avg. volume
194,403
P/E ratio
-.54
Repare Therapeutics News
Details
Daily high
$1.09
Daily low
$1.03
Price at open
$1.07
52 Week High
$4.90
52 Week Low
$1.03
Market cap
45.9M
Dividend yield
0.00%
Volume
267,997
Avg. volume
194,403
P/E ratio
-.54